3M (NYSE: MMM) is revisiting a potential divestiture of Health Information Systems, its health care revenue cycle management and software arm, sources tell Axios.
Why it matters: HIS is a large, profitable and high-quality RCM business, and should arguably be valued at a higher multiple than the conglomerate that it sits under. That said, the future growth opportunity as, hypothetically, a standalone business, is not clear.
/2022/04/25/1650913116775.gif?w=3840)
